Evidence map›Paper›PMID 34830136›Full record

ArticleInternational journal of molecular sciences2021

Optimization, Characterization and Pharmacokinetic Study of Meso-Tetraphenylporphyrin Metal Complex-Loaded PLGA Nanoparticles.

Mariia R Mollaeva, Nikita Yabbarov, Maria Sokol, Margarita Chirkina, Murad D Mollaev, Artur Zabolotskii, Irina Seregina, Mikhail Bolshov, Alexander Kaplun, Elena Nikolskaya

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Recent Advances in Nanoparticle-Mediated Antibacterial Photodynamic Therapy.International journal of molecular sciences · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Radiolabeling of Micro-/Nanoplastics via In-Diffusion.Nanomaterials (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Fluoroplast Doped by AgInternational journal of molecular sciences · 2023
    Article
  15. Article
  16. Article
  17. Synergetic Enhancement of Tumor Double-Targeted MRI Nano-Probe.International journal of molecular sciences · 2022
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Mariia R MollaevaN.M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119991 Moscow, Russia.
Nikita YabbarovN.M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0003-3361-9136
Maria SokolN.M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119991 Moscow, Russia.
Margarita ChirkinaN.M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119991 Moscow, Russia.
Murad D MollaevJSC Russian Research Center for Molecular Diagnostics and Therapy, 117149 Moscow, Russia.
Artur ZabolotskiiJSC Russian Research Center for Molecular Diagnostics and Therapy, 117149 Moscow, Russia.
Irina SereginaChemistry Department, Lomonosov Moscow State University, 119234 Moscow, Russia.
Mikhail BolshovChemistry Department, Lomonosov Moscow State University, 119234 Moscow, Russia.ORCID 0000-0003-2506-8629
Alexander KaplunLomonosov Institute of Fine Chemical Technologies, MIREA-Russian Technological University, 119454 Moscow, Russia.
Elena NikolskayaN.M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0002-1931-3117
Russian Research Center for Molecular Diagnostics and Therapy · RULomonosov Moscow State University · RUMIREA - Russian Technological University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The selection of technological parameters for nanoparticle formulation represents a complicated development phase. Therefore, the statistical analysis based on Box-Behnken methodology is widely used to optimize technological processes, including poly(lactic-co-glycolic acid) nanoparticle formulation. In this study, we applied a two-level three-factor design to optimize the preparation of nanoparticles loaded with cobalt (CoTPP), manganese (MnClTPP), and nickel (NiTPP) metalloporphyrins (MeP). The resulting nanoparticles were examined by dynamic light scattering, X-ray diffraction, Fourier transform infrared spectroscopy, MTT test, and hemolytic activity assay. The optimized model of nanoparticle formulation was validated, and the obtained nanoparticles possessed a spherical shape and physicochemical characteristics enabling them to deliver MeP in cancer cells. In vitro hemolysis assay revealed high safety of the formulated MeP-loaded nanoparticles. The MeP release demonstrated a biphasic profile and release mechanism via Fick diffusion, according to release exponent values. Formulated MeP-loaded nanoparticles revealed significant antitumor activity and ability to generate reactive oxygen species. MnClTPP- and CoTPP-nanoparticles specifically accumulated in tissues, preventing wide tissue distribution caused by long-term circulation of the hydrophobic drug. Our results suggest that MnClTPP- and CoTPP-nanoparticles represent the greatest potential for utilization in in anticancer therapy due to their effectiveness and safety.

Indexed as

AnimalsCell Line, TumorCell SurvivalCoordination ComplexesDrug LiberationFemaleHeLa CellsHemolysisHumansMCF-7 CellsMetalloporphyrinsMetalsMiceMice, Inbred BALB CMicroscopy, Electron, TransmissionNanoparticlesCoordination ComplexesMetalloporphyrinsMetalsPolylactic Acid-Polyglycolic Acid CopolymerPorphyrinstetraphenylporphinebinding constantBox–Behnken designdrug releasehemolytic activitykineticsmetalloporphyrinsnanoparticlespharmacokineticsPLGA

Identifiers

PMID34830136
PMCPMC8618356
OpenAlexW3213241415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.